» Articles » PMID: 20623995

Clearance of HIV Type 1 Envelope Recombinant Sendai Virus Depends on CD4+ T Cells and Interferon-gamma but Not B Cells, CD8+ T Cells, or Perforin

Overview
Publisher Mary Ann Liebert
Date 2010 Jul 14
PMID 20623995
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

T cell-mediated viral clearance is classically attributed to the CD8(+) T cell subset, but CD4(+) T cells can sometimes assume this role. One such instance was illustrated by the immunization of C57BL/6 mice with HIV-1 envelope, followed by challenge with a recombinant Sendai virus (rSeV-env) carrying a gene for secreted HIV-1 envelope protein. Vaccinated mice that lacked both B cells (microMT) and CD8(+) T cells controlled virus, but control was lost when CD4(+) T cells were depleted. To explain this activity, we questioned whether CD4(+) T cells might utilize perforin for killing of MHC class II-positive targets. We also asked if the process might depend on IFN-gamma, which can upregulate MHC expression and enhance T cell recruitment to sites of virus challenge. To address these possibilities, we vaccinated perforin-KO mice with HIV-1 envelope and challenged them with rSeV-env. We found that perforin was not required for (1) CD4(+) T cell homing to the site of virus challenge, (2) expression of Th1 and Th2 cytokines (including IFN-gamma), or (3) virus clearance. To determine if IFN-gamma was required for protection, we repeated experiments in IFN-gamma-KO animals. In this case, significant protection was lost, although the CD4(+) T cells trafficked readily to the site of infection. In fact, local CD4(+) T cell numbers in vaccinated IFN-gamma- KO mice exceeded those in wild type animals. In both cases, cells were alphass TCR(+), NK-1.1(-), and CD44(+), typifying an activated CD4(+) T cell subset. Taken together, our results showed that HIV-1 envelope recombinant virus clearance was dependent on CD4(+) T cells and IFN-gamma, but occurred in the absence of B cells, CD8(+) T cells, or perforin.

Citing Articles

CD4 T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.

Sealy R, Surman S, Hurwitz J Vaccine. 2017; 35(20):2617-2621.

PMID: 28410812 PMC: 5588898. DOI: 10.1016/j.vaccine.2017.03.073.


Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines.

Sealy R, Webby R, Crumpton J, Hurwitz J Int Immunol. 2012; 25(3):183-95.

PMID: 23143476 PMC: 3579181. DOI: 10.1093/intimm/dxs107.


UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.

Jones B, Sealy R, Zhan X, Freiden P, Surman S, Blanchard J Vaccine. 2012; 30(21):3188-95.

PMID: 22425790 PMC: 3386644. DOI: 10.1016/j.vaccine.2012.03.001.


Respiratory syncytial virus vaccine development.

Hurwitz J Expert Rev Vaccines. 2011; 10(10):1415-33.

PMID: 21988307 PMC: 3255794. DOI: 10.1586/erv.11.120.

References
1.
Lehner T, Tao L, Panagiotidi C, Klavinskis L, Brookes R, Hussain L . Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol. 1994; 68(3):1624-32. PMC: 236620. DOI: 10.1128/JVI.68.3.1624-1632.1994. View

2.
Williams M, Holmes B, Sun J, Bevan M . Developing and maintaining protective CD8+ memory T cells. Immunol Rev. 2006; 211:146-53. DOI: 10.1111/j.0105-2896.2006.00389.x. View

3.
Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T . Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett. 1999; 456(2):221-6. DOI: 10.1016/s0014-5793(99)00960-6. View

4.
Tay S, McCormack A, Lawson C, Rose M . IFN-gamma reverses the stop signal allowing migration of antigen-specific T cells into inflammatory sites. J Immunol. 2003; 170(6):3315-22. DOI: 10.4049/jimmunol.170.6.3315. View

5.
Junt T, Moseman E, Iannacone M, Massberg S, Lang P, Boes M . Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007; 450(7166):110-4. DOI: 10.1038/nature06287. View